Read + Share
Bigaut K, Kremer L, Fabacher T, Ahle G, et al. Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis:
an observational study. J Neurol 2022 Jan 4. pii: 10.1007/s00415-021-10950.
PMID: 34982200
|
 |
|
Bigaut K, Kremer L, Fabacher T, Ahle G, et al. Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis:
an observational study. J Neurol 2022 Jan 4. pii: 10.1007/s00415-021-10950.
PMID: 34982200
|
|
|
|